Related Experiment Videos

Occurrence of withdrawal in critically ill sedated children

L Fonsmark1, Y H Rasmussen, P Carl

  • 1Department of Anaesthesiology and Intensive Care, Gentofte Hospital, University of Copenhagen, Gentofte, Denmark.

Critical Care Medicine
|February 6, 1999
PubMed

Insights

High doses of midazolam in sedated children undergoing mechanical ventilation were linked to withdrawal symptoms. Gradual dose reduction or alternative sedatives may help prevent these reactions.

Area of Science:

  • Pediatric Critical Care
  • Pharmacology
  • Intensive Care Medicine

Background:

  • Sedation is frequently used in pediatric intensive care units (ICUs) for mechanical ventilation.
  • Withdrawal symptoms can occur after discontinuing sedative medications.
  • Midazolam is a common sedative used in this population.

Purpose of the Study:

  • To determine the incidence of withdrawal symptoms in children sedated for mechanical ventilation.
  • To investigate the association between midazolam administration and withdrawal symptoms.

Main Methods:

  • Retrospective chart review of 40 children (6 months to 14 years) in a university hospital ICU.
  • Data collected on sedative/analgesic types, doses, duration, and withdrawal occurrence.
  • Statistical analysis to identify factors associated with withdrawal.

Main Results:

  • Withdrawal symptoms were observed in 35% (14/40) of sedated children.
  • High total doses of midazolam (>60 mg/kg) were significantly associated with withdrawal.
  • The influence of morphine on withdrawal could not be statistically determined.

Conclusions:

  • Withdrawal reactions are a concern in pediatric patients receiving prolonged sedation.
  • High-dose midazolam is a significant risk factor for withdrawal.
  • Consider gradual tapering of sedatives or using longer-acting agents to mitigate withdrawal risks.
Abstract

Related Concept Videos